华东医药

- 000963

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012 
华东医药(000963) 利润表
单位:万元
报表日期2022-06-302022-03-312021-12-312021-09-302021-06-30
一、营业总收入1,819,796.40893,257.933,456,330.122,592,747.741,717,943.79
营业收入1,819,796.40893,257.933,456,330.122,592,747.741,717,943.79
二、营业总成本1,651,651.54802,812.933,172,733.632,372,102.041,563,878.87
营业成本1,224,337.41591,489.892,395,737.071,782,026.461,158,941.99
营业税金及附加9,608.364,986.8617,725.3313,207.168,858.54
销售费用303,296.52143,349.31542,405.19416,525.56297,875.38
管理费用57,204.8230,260.11116,694.1385,993.2953,468.34
财务费用544.80806.022,207.511,589.90978.96
研发费用56,659.6431,920.7297,964.4072,759.6643,755.67
资产减值损失----------
公允价值变动收益----------
投资收益-5,347.90-2,796.15-9,631.20-6,000.15-5,445.90
其中:对联营企业和合营企业的投资收益-4,314.53-2,076.40-5,343.33-1,897.03-2,285.25
汇兑收益----------
三、营业利润164,616.4088,771.53285,571.35226,906.22158,852.83
加:营业外收入434.1683.16268.231,743.9183.49
减:营业外支出866.15535.593,086.081,988.86612.69
其中:非流动资产处置损失----------
四、利润总额164,184.4188,319.10282,753.49226,661.27158,323.63
减:所得税费用28,793.8716,915.8448,890.7432,443.5824,072.85
五、净利润135,390.5471,403.26233,862.76194,217.70134,250.78
归属于母公司所有者的净利润134,057.0570,436.48230,163.13189,538.46130,034.63
少数股东损益1,333.49966.783,699.624,679.244,216.15
六、每股收益
基本每股收益(元/股)0.76610.40251.31541.08320.7431
稀释每股收益(元/股)0.76610.40251.31541.08320.7431
七、其他综合收益-9,825.27-1,501.48-2,407.6311,559.674,956.27
八、综合收益总额125,565.2769,901.78231,455.12205,777.37139,207.05
归属于母公司所有者的综合收益总额124,231.7868,935.00227,755.50201,098.13134,990.90
归属于少数股东的综合收益总额1,333.49966.783,699.624,679.244,216.15
下载全部历史数据到excel中 返回页顶